Cancer Core Europe: A translational research infrastructure for a European mission on cancer

Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres – most of them Comprehensive Cancer Centres (CCCs) – with a single portal system to engage in various research projects with partners. Cancer Core Europe was established to create a sustainable, high‐level, shared research infrastructure platform hosting research collaborations and task forces (data sharing, clinical trials, genomics, immunotherapy, imaging, education and training, and legal and ethical issues), with a controlled expansion agenda. Translational cancer research covers the cancer research continuum from basic to preclinical to early clinical, late clinical, and outcomes research. Basic–preclinical research serves as the ‘engine’ for early clinical research by bridging the early translational research gap and is the primary and current focus of the consortium as exemplified by the launching of the Basket of Baskets trial, Europe's largest precision cancer medicine trial. Inspired by the creation of Cancer Core Europe, the prevention community established Cancer Prevention Europe, a consortium of ten cancer prevention centres aimed at supporting the complete prevention research continuum. Presently, Cancer Core Europe and Cancer Prevention Europe are integrating therapeutics and prevention strategies to address in partnership the widening cancer problem. By providing innovative approaches for cancer research, links to healthcare systems, development of quality‐assured multidisciplinary cancer care, and assessment of long‐term outcomes, the virtual infrastructure will serve as a hub to connect and interact with other centres across Europe and beyond. Together, Cancer Core Europe and Cancer Prevention Europe are prepared to function as a central engine to tackle, in collaboration with various partners, a potential ‘mission on cancer’ addressing the cancer burden.

[1]  C. Caldas,et al.  Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century. , 2018, European journal of cancer.

[2]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[3]  D. Forman,et al.  Time for a European initiative for research to prevent cancer: A manifesto for Cancer Prevention Europe (CPE) , 2018, Journal of Cancer Policy.

[4]  E. Birney,et al.  A roadmap for restoring trust in Big Data. , 2018, The Lancet Oncology.

[5]  S. Stearns,et al.  The transition to modernity and chronic disease: mismatch and natural selection , 2018, Nature Reviews Genetics.

[6]  A. Berns,et al.  European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence. , 2018, European Journal of Cancer.

[7]  J. Celis,et al.  A mission‐oriented approach to cancer in Europe: a joint mission/vision 2030 , 2017, Molecular oncology.

[8]  B. Jönsson,et al.  The cost and burden of cancer in the European Union 1995-2014. , 2016, European journal of cancer.

[9]  R. Sullivan,et al.  ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  C. Caldas,et al.  Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. , 2014, European journal of cancer.

[11]  Richard Sullivan,et al.  Economic burden of cancer across the European Union: a population-based cost analysis. , 2013, The Lancet. Oncology.

[12]  Karol Sikora,et al.  Delivering affordable cancer care in high-income countries. , 2011, The Lancet. Oncology.